Flávia Sayuri Matsuo

Flávia Sayuri Matsuo

Auto-generated profile, based on publicly available information

Flávia Sayuri Matsuo

Department of Cell and Molecular Biology

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
RMRyerson Fonseca Mota
Ryerson Fonseca Mota
PAPaulo Henrique Cavalcanti de Araújo
Paulo Henrique Cavalcanti de Araújo
MCMaria Eduarda Ramos Cezine
Maria Eduarda Ramos Cezine
FMFlávia Sayuri Matsuo
Flávia Sayuri Matsuo
RMRodrigo Jair Morandi Metzner
Rodrigo Jair Morandi Metzner
MOMariana Kiomy Osako
Mariana Kiomy Osako
High serum levels of osteoprotegerin (OPG) are found in patients with obesity, type 2 diabetes, sepsis, or septic shock and are associated with a high mortality rate in stroke. The primary known function of OPG is to bind to the receptor activator of NF‐κB ligand (RANKL), and by doing so, it inhibits the binding between RANKL and its receptor (RANK). TLR4 signaling in macrophages involves TRAF6 recruitment and contributes to low‐grade chronic inflammation in adipose tissue. LPS is a classical activator of the TLR4 pathway and induces the expression of inflammatory cytokines in macrophages. We have previously observed that in the presence of RANKL, there is no LPS‐induced activation of TLR4 in macrophages. In this study, we investigated the crosstalk between RANK and TLR4 pathways in macrophages stimulated with both RANKL and LPS to unveil the role of OPG in inflammatory processes. We found that RANKL inhibits TLR4 activation by binding to RANK, promoting the binding between TRAF6 and RANK, lowering TLR4 activation and the expression of proinflammatory mediators. Furthermore, high OPG levels aggravate inflammation by inhibiting RANKL. Our findings elect RANKL as a candidate for drug development as a way to mitigate the impact of obesity‐induced inflammation in patients.

18 May 2013 in Case Reports in Dentistry
Verified
Journal Article
Open access
PDF file
FMFlávia Sayuri Matsuo
Flávia Sayuri Matsuo
ABAlceu Luiz Camargo Villela Berbert
Alceu Luiz Camargo Villela Berbert
SMSônia Antunes de Oliveira Mantese
Sônia Antunes de Oliveira Mantese
ALAdriano Mota Loyola
Adriano Mota Loyola
SCSérgio Vitorino Cardoso
Sérgio Vitorino Cardoso
PFPaulo Rogério De Faria
Paulo Rogério De Faria
Pseudoxanthoma elasticum (PXE) is an inherited multisystemic disease of elastic fibers that primarily affects the skin and retina. A case of primary PXE of the skin with late involvement of the upper lip is reported. A 55-year-old woman with a previous diagnosis of PXE affecting her skin developed a lesion on her lower lip. An oral examination identified a yellowish macule of undefined limits. A biopsy from her lip was taken and both light and transmission electron microscopies confirmed the presence of fragmented elastic fibers and calcifications on her mucosa, which was compatible with the diagnosis of oral PXE. Since the manifestation of oral PXE is rare in this region, dental practitioners must be aware that this systemic condition may produce oral lesions, which sometimes may mimic other benign diseases of the oral cavity like Fordyce granules. So, the establishment of an appropriate diagnosis is necessary to provide adequate information and attention to the patient.